ArticlePloS one2026

Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study.

Kazuma Nishisaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.